Lia Palomba

835 total citations
14 papers, 289 citations indexed

About

Lia Palomba is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, Lia Palomba has authored 14 papers receiving a total of 289 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pathology and Forensic Medicine, 8 papers in Oncology and 7 papers in Genetics. Recurrent topics in Lia Palomba's work include Lymphoma Diagnosis and Treatment (8 papers), Chronic Lymphocytic Leukemia Research (7 papers) and CAR-T cell therapy research (4 papers). Lia Palomba is often cited by papers focused on Lymphoma Diagnosis and Treatment (8 papers), Chronic Lymphocytic Leukemia Research (7 papers) and CAR-T cell therapy research (4 papers). Lia Palomba collaborates with scholars based in United States, Italy and Germany. Lia Palomba's co-authors include Ariela Noy, Paul A. Hamlin, Matthew J. Matasar, Craig H. Moskowitz, Steven M. Horwitz, Heiko Schöder, Alison J. Moskowitz, Andrew D. Zelenetz, Carol S. Portlock and David J. Straus and has published in prestigious journals such as Blood, Annals of Oncology and British Journal of Haematology.

In The Last Decade

Lia Palomba

12 papers receiving 287 citations

Peers

Lia Palomba

PFM

ONCOL

NEURO

PRM

RNMI

Antonella Anastasia Italy

Gaetana Capobianco Italy

M. Dreyling Germany

Marita Kloess Germany

Julie Lisano United States

Rita Mazza Italy

Akash Nahar United States

Hanne Kuitunen Finland

Emanuela Anna Pesce Italy

Joël Fleury France

Antonella Anastasia Italy

Lia Palomba

216 ×0.9

PFM

161 ×1.0

ONCOL

92 ×0.8

NEURO

44 ×0.8

PRM

17 ×0.3

RNMI

Citations per year, relative to Lia Palomba Lia Palomba (= 1×) peers Antonella Anastasia

Countries citing papers authored by Lia Palomba

Since Specialization

Citations

This map shows the geographic impact of Lia Palomba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lia Palomba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lia Palomba more than expected).

Fields of papers citing papers by Lia Palomba

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lia Palomba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lia Palomba. The network helps show where Lia Palomba may publish in the future.

Co-authorship network of co-authors of Lia Palomba

This figure shows the co-authorship network connecting the top 25 collaborators of Lia Palomba. A scholar is included among the top collaborators of Lia Palomba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lia Palomba. Lia Palomba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Torre, Michele, Rachele Bonfiglio, Maria Grazia Calevo, et al.. (2025). Cryoanalgesia for Pain Management After Pectus Excavatum Repair (COPPER) in Adolescents: A Randomized Controlled Trial. Pediatric Anesthesia. 35(5). 347–358.

Munshi, Manit, Xia Liu, Amanda Kofides, et al.. (2024). ERK1/2 pro‐survival signalling is suppressed by pirtobrutinib in ibrutinib‐resistant MYD88‐mutated lymphoma cells. British Journal of Haematology. 205(5). 1866–1872.

Maclachlan, Kylee, Tina Bagratuni, Efstathios Kastritis, et al.. (2022). Waldenström macroglobulinemia whole genome reveals prolonged germinal center activity and late copy number aberrations. Blood Advances. 7(6). 971–981. 1 indexed citations

Treon, Steven P., Kirsten Meid, Joshua Gustine, et al.. (2019). IBRUTINIB MONOTHERAPY PRODUCES LONG‐TERM DISEASE CONTROL IN PREVIOUSLY TREATED WALDENSTROM'S MACROGLOBULINEMIA. FINAL REPORT OF THE PIVOTAL TRIAL (NCT01614821).. Hematological Oncology. 37(S2). 184–185. 12 indexed citations

Castillo, Jorge J., Gilad Itchaki, Jonas Paludo, et al.. (2019). IBRUTINIB FOR THE TREATMENT OF BING‐NEEL SYNDROME: A RETROSPECTIVE, MULTICENTER STUDY. Hematological Oncology. 37(S2). 183–184. 1 indexed citations

Borchmann, Sven, Erel Joffe, Craig H. Moskowitz, et al.. (2017). Active Surveillance for Newly Diagnosed Nodular Lymphocyte-Predominant Hodgkin Lymphoma. Blood. 130(Suppl_1). 654–654. 1 indexed citations

Ni, Ai, John F. Gerecitano, Paul A. Hamlin, et al.. (2016). Incidence of Infectious Complications Associated with Bendamustine and Anti-CD20 Monoclonal Antibody Combination at Memorial Sloan Kettering Cancer Center (MSKCC). Blood. 128(22). 1778–1778. 3 indexed citations

Abramson, Jeremy S., Lia Palomba, Leo I. Gordon, et al.. (2016). Transcend NHL 001: Immunotherapy with the CD19-Directed CAR T-Cell Product JCAR017 Results in High Complete Response Rates in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma. Blood. 128(22). 4192–4192. 29 indexed citations

Schöder, Heiko, Andrew D. Zelenetz, Paul A. Hamlin, et al.. (2015). Prospective Study of 3′-Deoxy-3′-¹⁸F-Fluorothymidine PET for Early Interim Response Assessment in Advanced-Stage B-Cell Lymphoma. Journal of Nuclear Medicine. 57(5). 728–734. 30 indexed citations

10.

Argyropoulos, Kimon V., Sarah McCue Horwitz, Franck Rapaport, et al.. (2015). High-Depth, Targeted, Next Generation Sequencing Identifies Novel Genetic Alterations in Cutaneous T-Cell Lymphoma. Blood. 126(23). 1485–1485. 1 indexed citations

11.

Stathis, Anastasios, Arnold S. Freedman, Ian W. Flinn, et al.. (2014). A Phase I Study of IMGN529, an Antibody-Drug Conjugate (ADC) Targeting CD37, in Adult Patients with Relapsed or Refractory B-Cell Non-Hodgkin’s Lymphoma (NHL). Blood. 124(21). 1760–1760. 14 indexed citations

12.

Moskowitz, Craig H., Matthew J. Matasar, Andrew D. Zelenetz, et al.. (2011). Normalization of pre-ASCT, FDG-PET imaging with second-line, non–cross-resistant, chemotherapy programs improves event-free survival in patients with Hodgkin lymphoma. Blood. 119(7). 1665–1670. 178 indexed citations

13.

Portlock, C., Paul A. Hamlin, Ariela Noy, et al.. (2007). Infectious disease associations in advanced stage, indolent lymphoma (follicular and nonfollicular): developing a lymphoma prevention strategy. Annals of Oncology. 19(2). 254–258. 5 indexed citations

14.

Harnaha, Jo, et al.. (1991). Effect of selective depletion of natural killer cells on allograft rejection.. Transplantation Proceedings. 23(1 Pt 1). 178–9. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact